Sialic acid residues are essential for cell lysis mediated by leukotoxin from Aggregatibacter actinomycetemcomitans

Infection and Immunity

Volumn 82, Issue 6, 2014, Pages 2219-2228

  Munksgaard, Peter Svenssen ^a   Skals, Marianne ^a   Reinholdt, Jesper ^a   Poulsen, Knud ^a   Jensen, Maria Risager ^a   Yang, Chuanxu ^b   Leipziger, Jens ^a   Vorup Jensen, Thomas ^a   Praetorius, Helle A ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HEMOLYSIN; CD18 ANTIGEN; LEUKOTOXIN; SIALIC ACID DERIVATIVE; EXOTOXIN; N ACETYLNEURAMINIC ACID;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANIMAL CELL; ARTICLE; CELL MEMBRANE; CONTROLLED STUDY; CYTOLYSIS; ERYTHROCYTE; ESCHERICHIA COLI; HEMOLYSIS; HUMAN; HUMAN CELL; K562 CELL LINE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURFACE CHARGE; ANALYSIS OF VARIANCE; ANIMAL; CELL DEATH; CELL LINE; CHEMISTRY; DRUG EFFECTS; METABOLISM; PHYSIOLOGY; RABBIT; SHEEP; TOXICITY;

AGGREGATIBACTER ACTINOMYCETEMCOMITANS; ANALYSIS OF VARIANCE; ANIMALS; ANTIGENS, CD18; CELL DEATH; CELL LINE; ERYTHROCYTES; EXOTOXINS; HUMANS; MICE; N-ACETYLNEURAMINIC ACID; RABBITS; SHEEP;

EID: 84900448201     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01647-14     Document Type: Article

References (70)

1. Slots J, Ting M. 1999. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in human periodontal disease: occurrence and treatment. Periodontology 2000 20:82-121. http://dx.doi.org/10.1111/j.1600-0757.1999.tb00159.x.
2. Haubek D, Ennibi OK, Poulsen K, Vaeth M, Poulsen S, Kilian M. 2008. Risk of aggressive periodontitis in adolescent carriers of the JP2 clone of Aggregatibacter (Actinobacillus) actinomycetemcomitans in Morocco: a prospective longitudinal cohort study. Lancet 371:237-242. http://dx.doi.org/10.1016/S0140-6736(08)60135-X.
3. Pihlstrom BL, Michalowicz BS, Johnson NW. 2005. Periodontal diseases. Lancet 366:1809-1820. http://dx.doi.org/10.1016/S0140-6736(05) 67728-8.
4. Slots J, Reynolds HS, Genco RJ. 1980. Actinobacillus actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. Infect. Immun. 29:1013-1020.
5. Paturel L, Casalta JP, Habib G, Nezri M, Raoult D. 2004. Actinobacillus actinomycetemcomitans endocarditis. Clin. Microbiol. Infect. 10:98-118. http://dx.doi.org/10.1111/j.1469-0691.2004.00794.x.
6. van Winkelhoff AJ, Slots J. 1999. Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis in nonoral infections. Periodontology 2000 20:122-135. http://dx.doi.org/10.1111/j.1600-0757.1999.tb00160.x.
7. Kachlany SC, Schwartz AB, Balashova NV, Hioe CE, Tuen M, Le A, Kaur M, Mei Y, Rao J. 2010. Anti-leukemia activity of a bacterial toxin with natural specificity for LFA-1 on white blood cells. Leukemia Res. 34:777-785. http://dx.doi.org/10.1016/j.leukres.2009.08.022.
8. Haraszthy VI, Hariharan G, Tinoco EM, Cortelli JR, Lally ET, Davis E, Zambon JJ. 2000. Evidence for the role of highly leukotoxic Actinobacillus actinomycetemcomitans in the pathogenesis of localized juvenile and other forms of early-onset periodontitis. J. Periodontol. 71:912-922. http://dx.doi.org/10.1902/jop.2000.71.6.912.
9. Haubek D, Ennibi OK, Poulsen K, Poulsen S, Benzarti N, Kilian M. 2001. Early-onset periodontitis in Morocco is associated with the highly leukotoxic clone of Actinobacillus actinomycetemcomitans. J. Dent. Res. 80:1580-1583. http://dx.doi.org/10.1177/00220345010800062001.
10. Lally ET, Golub EE, Kieba IR. 1994. Identification and immunological characterization of the domain of Actinobacillus actinomycetemcomitans leukotoxin that determines its specificity for human target cells. J. Biol. Chem. 269:31289-31295.
11. Linhartova I, Bumba L, Masin J, Basler M, Osicka R, Kamanova J, Prochazkova K, Adkins I, Hejnova-Holubova J, Sadilkova L, Morova J, Sebo P. 2010. RTX proteins: a highly diverse family secreted by a common mechanism. FEMS Microbiol. Rev. 34:1076-1112.
12. Sanchez-Magraner L, Viguera AR, Garcia-Pacios M, Garcillan MP, Arrondo JL, de la Cruz F, Goni FM, Ostolaza H. 2007. The calciumbinding C-terminal domain of Escherichia coli α-hemolysin is a major determinant in the surface-active properties of the protein. J. Biol. Chem. 282:11827-11835. http://dx.doi.org/10.1074/jbc.M700547200.
13. Iwase M, Lally ET, Berthold P, Korchak HM, Taichman NS. 1990. Effects of cations and osmotic protectants on cytolytic activity of Actinobacillus actinomycetemcomitans leukotoxin. Infect. Immun. 58:1782-1788.
14. Lear JD, Furblur UG, Lally ET, Tanaka JC. 1995. Actinobacillus actinomycetemcomitans leukotoxin forms large conductance, voltage-gated ion channels when incorporated into planar lipid bilayers. Biochim. Biophys. Acta 1238:34-41. http://dx.doi.org/10.1016/0005-2736(95)00086-I.
15. Brown AC, Boesze-Battaglia K, Du Y, Stefano FP, Kieba IR, Epand RF, Kakalis L, Yeagle PL, Epand RM, Lally ET. 2012. Aggregatibacter actinomycetemcomitans leukotoxin cytotoxicity occurs through bilayer destabilization. Cell. Microbiol. 14:869-881. http://dx.doi.org/10.1111/j.1462-5822.2012.01762.x.
16. Taichman NS, Shenker BJ, Tsai CC, Glickman LT, Baehni PC, Stevens R, Hammond BF. 1984. Cytopathic effects of Actinobacillus actinomycetemcomitans on monkey blood leukocytes. J. Periodontal Res. 19:133-145. http://dx.doi.org/10.1111/j.1600-0765.1984.tb00802.x.
17. Taichman NS, Simpson DL, Sakurada S, Cranfield M, DiRienzo J, Slots J. 1987. Comparative studies on the biology of Actinobacillus actinomycetemcomitans leukotoxin in primates. Oral Microbiol. Immunol. 2:97-104. http://dx.doi.org/10.1111/j.1399-302X.1987.tb00270.x.
18. Tsai CC, McArthur WP, Baehni PC, Hammond BF, Taichman NS. 1979. Extraction and partial characterization of a leukotoxin from a plaque-derived Gram-negative microorganism. Infect. Immun. 25:427-439.
19. Johansson A, Sandstrom G, Claesson R, Hanstrom L, Kalfas S. 2000. Anaerobic neutrophil-dependent killing of Actinobacillus actinomycetemcomitans in relation to the bacterial leukotoxicity. Eur. J. Oral Sci. 108:136-146. http://dx.doi.org/10.1034/j.1600-0722.2000.00790.x.
20. Venketaraman V, Lin AK, Le A, Kachlany SC, Connell ND, Kaplan JB. 2008. Both leukotoxin and poly-N-acetylglucosamine surface polysaccharide protect Aggregatibacter actinomycetemcomitans cells from macrophage killing. Microb. Pathog. 45:173-180. http://dx.doi.org/10.1016/j.micpath.2008.05.007.
21. Johansson A, Claesson R, Hanstrom L, Sandstrom G, Kalfas S. 2000. Polymorphonuclear leukocyte degranulation induced by leukotoxin from Actinobacillus actinomycetemcomitans. J. Periodontal Res. 35:85-92. http://dx.doi.org/10.1034/j.1600-0765.2000.035002085.x.
22. Kelk P, Abd H, Claesson R, Sandstrom G, Sjostedt A, Johansson A. 2011. Cellular and molecular response of human macrophages exposed to Aggregatibacter actinomycetemcomitans leukotoxin. Cell Death Dis. 2:e126. http://dx.doi.org/10.1038/cddis.2011.6.
23. Kelk P, Claesson R, Chen C, Sjostedt A, Johansson A. 2008. IL-1beta secretion induced by Aggregatibacter (Actinobacillus) actinomycetemcomitans is mainly caused by the leukotoxin. Int. J. Med. Microbiol. 298: 529-541. http://dx.doi.org/10.1016/j.ijmm.2007.06.005.
24. Kieba IR, Fong KP, Tang HY, Hoffman KE, Speicher DW, Klickstein LB, Lally ET. 2007. Aggregatibacter actinomycetemcomitans leukotoxin requires sheets 1 and 2 of thehuman CD11a propeller for cytotoxicity. Cell. Microbiol. 9:2689-2699. http://dx.doi.org/10.1111/j.1462-5822.2007.00989.x.
25. Lally ET, Kieba IR, Sato A, Green CL, Rosenbloom J, Korostoff J, Wang JF, Shenker BJ, Ortlepp S, Robinson MK, Billings PC. 1997. RTX toxins recognize β2 integrin on the surface of human target cells. J. Biol. Chem. 272:30463-30469. http://dx.doi.org/10.1074/jbc.272.48.30463.
26. Morova J, Osicka R, Masin J, Sebo P. 2008. RTX cytotoxins recognize β2 integrin receptors through N-linked oligosaccharides. Proc. Natl. Acad. Sci. U. S. A. 105:5355-5360. http://dx.doi.org/10.1073/pnas.0711400105.
27. Reinholdt J, Poulsen K, Brinkmann CR, Hoffmann SV, Stapulionis R, Enghild JJ, Jensen UB, Boesen T, Vorup-Jensen T. 2013. Monodisperse and LPS-free Aggregatibacter actinomycetemcomitans leukotoxin: interactions with human β2 integrins and erythrocytes. Biochim. Biophys. Acta 1834:546-558. http://dx.doi.org/10.1016/j.bbapap.2012.12.004.
28. Mazzone A, Ricevuti G. 1995. Leukocyte CD11/CD18 integrins: biological and clinical relevance. Haematologicaae 80:161-175.
29. Tan SM. 2012. The leucocyte beta2 (CD18) integrins: the structure, functional regulation and signalling properties. Biosci. Rep. 32:241-269. http://dx.doi.org/10.1042/BSR20110101.
30. Luo BH, Carman CV, Springer TA. 2007. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25:619-647. http://dx.doi.org/10.1146/annurev.immunol.25.022106.141618.
31. DiFranco KM, Gupta A, Galusha LE, Perez J, Nguyen TV, Fineza CD, Kachlany SC. 2012. Leukotoxin (Leukothera(R)) targets active leukocyte function antigen-1 (LFA-1) protein and triggers a lysosomal mediated cell death pathway. J. Biol. Chem. 287:17618-17627. http://dx.doi.org/10.1074/jbc.M111.314674.
32. Papayannopoulou T, Brice M. 1992. Integrin expression profiles during erythroid differentiation. Blood 79:1686-1694.
33. Pasini EM, Kirkegaard M, Mortensen P, Lutz HU, Thomas AW, Mann M. 2006. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108:791-801. http://dx.doi.org/10.1182/blood-2005-11-007799.
34. Avila-Campos MJ. 1995. Haemolytic activity of Actinobacillus actinomycetemcomitans strains on different blood types. Rev. Inst. Med. Trop. Sao Paulo 37:215-217. http://dx.doi.org/10.1590/S0036-46651995000300006.
35. Bergley DH, Hiolt JG. 1994. Bergey's manual of determinative bacteriology. Lippincot, Williams & Wilkins, Baltimore, MD, USA.
36. Balashova NV, Crosby JA, Al Ghofaily L, Kachlany SC. 2006. Leukotoxin confers beta-hemolytic activity to Actinobacillus actinomycetemcomitans. Infect. Immun. 74:2015-2021. http://dx.doi.org/10.1128/IAI.74.4.2015-2021.2006.
37. Forman MS, Nishikubo JB, Han RK, Le A, Balashova NV, Kachlany SC. 2010. Gangliosides block Aggregatibacter actinomycetemcomitans leukotoxin (LtxA)-mediated hemolysis. Toxins (Basel) 2:2824-2836. http://dx.doi.org/10.3390/toxins2122824.
38. Munksgaard P, Vorup-Jensen T, Reinholdt J, Soderstrom C, Poulsen K, Leipziger J, Praetorius H, Skals M. 2012. Leukotoxin from Aggregatibacter actinomycetemcomitans causes shrinkage and P2X receptor-dependent lysis of human erythrocytes. Cell. Microbiol. 4:1904-1920. http://dx.doi.org/10.1111/cmi.12021.
39. Skals MG, Jorgensen NR, Leipziger J, Praetorius HA. 2009. α-Hemolysin from Escherichia coli uses endogenous amplification through P2X receptor activation to induce hemolysis. Proc. Natl. Acad. Sci. U. S. A. 106:4030-4035. http://dx.doi.org/10.1073/pnas.0807044106.
40. Skals M, Jensen UB, Ousingsawat J, Kunzelmann K, Leipziger J, Praetorius HA. 2010. Escherichia coli α-hemolysin triggers shrinkage of erythrocytes via KCa3.1 and TMEM16A channels with subsequent phosphatidylserine exposure. J. Biol. Chem. 285:15557-15565. http://dx.doi.org/10.1074/jbc.M109.082578.
41. Lu CF, Springer TA. 1997. The alpha subunit cytoplasmic domain regulates the assembly and adhesiveness of integrin lymphocyte functionassociated antigen-1. J. Immunol. 159:268-278.
42. Larson RS, Springer TA. 1990. Structure and function of leukocyte integrins. Immunol. Rev. 114:181-217. http://dx.doi.org/10.1111/j.1600-065X.1990.tb00565.x.
43. Robinson MK, Andrew D, Rosen H, Brown D, Ortlepp S, Stephens P, Butcher EC. 1992. Antibody against the Leu-CAM beta-chain (CD18) promotes both LFA-1-and CR3-dependent adhesion events. J. Immunol. 148:1080-1085.
44. Gjelstrup LC, Boesen T, Kragstrup TW, Jorgensen A, Klein NJ, Thiel S, Deleuran BW, Vorup-Jensen T. 2010. Shedding of large functionally active CD11/CD18 integrin complexes from leukocyte membranes during synovial inflammation distinguishes three types of arthritis through differential epitope exposure. J. Immunol. 185:4154-4168. http://dx.doi.org/10.4049/jimmunol.1000952.
45. Hyland C, Vuillard L, Hughes C, Koronakis V. 2001. Membrane interaction of Escherichia coli hemolysin: flotation and insertion-dependent labeling by phospholipid vesicles. J. Bacteriol. 183:5364-5370. http://dx.doi.org/10.1128/JB.183.18.5364-5370.2001.
46. Ilver D, Johansson P, Miller-Podraza H, Nyholm PG, Teneberg S, Karlsson KA. 2003. Bacterium-host protein-carbohydrate interactions. Methods Enzymol. 363:134-157. http://dx.doi.org/10.1016/S0076-6879 (03)01049-8.
47. Merritt EA, Hol WG. 1995. AB5 toxins. Curr. Opin. Struct. Biol. 5:165-171. http://dx.doi.org/10.1016/0959-440X(95)80071-9.
48. Varki A. 2007. Glycan-based interactions involving vertebrate sialic-acidrecognizing proteins. Nature 446:1023-1029. http://dx.doi.org/10.1038/nature05816.
49. Reuter G, Vliegenthart JF, Wember M, Schauer R, Howard RJ. 1980. Identification of 9-O-acetyl-N-acetylneuraminic acid on the surface of BALB/c mouse erythrocytes. Biochem. Biophys. Res. Commun. 94:567-572. http://dx.doi.org/10.1016/0006-291X(80)91269-3.
50. Ish C, Ong GL, Desai N, Mattes MJ. 1993. The specificity of alternative complement pathway-mediated lysis of erythrocytes: a survey of complement and target cells from 25 species. Scand. J. Immunol. 38:113-122. http://dx.doi.org/10.1111/j.1365-3083.1993.tb01701.x.
51. Eylar EH, Madoff MA, Brody OV, Oncley JL. 1962. The contribution of sialic acid to the surface charge of the erythrocyte. J. Biol. Chem. 237: 1992-2000.
52. Guermonprez P, Khelef N, Blouin E, Rieu P, Ricciardi-Castagnoli P, Guiso N, Ladant D, Leclerc C. 2001. The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the αMβ2 integrin (CD11b/CD18). J. Exp. Med. 193:1035-1044. http://dx.doi.org/10.1084/jem.193.9.1035.
53. Fett T, Zecchinon L, Vanden Bergh P, Desmecht D. 2008. Mannheimia haemolytica leukotoxin-induced cytolysis of caprine (Capra hircus) leukocytes is mediated by the CD18 subunit of β2-integrins. Microb. Pathog. 45:337-342. http://dx.doi.org/10.1016/j.micpath.2008.08.001.
54. Larsen CK, Skals M, Wang T, Cheema MU, Leipziger J, Praetorius HA. 2011. Python erythrocytes are resistant to α-hemolysin from Escherichia coli. J. Membr. Biol. 244:131-140. http://dx.doi.org/10.1007/s00232-011-9406-2.
55. Valeva A, Walev I, Kemmer H, Weis S, Siegel I, Boukhallouk F, Wassenaar TM, Chavakis T, Bhakdi S. 2005. Binding of Escherichia coli hemolysin and activation of the target cells is not receptor-dependent. J. Biol. Chem. 280: 36657-36663. http://dx.doi.org/10.1074/jbc.M507690200.
56. Bhakdi S, Greulich S, Muhly M, Eberspacher B, Becker H, Thiele A, Hugo F. 1989. Potent leukocidal action of Escherichia coli hemolysin mediated by permeabilization of target cell membranes. J. Exp. Med. 169: 737-754. http://dx.doi.org/10.1084/jem.169.3.737.
57. Imberty A, Varrot A. 2008. Microbial recognition of human cell surface glycoconjugates. Curr. Opin. Struct. Biol. 18:567-576. http://dx.doi.org/10.1016/j.sbi.2008.08.001.
58. Jorgensen SE, Hammer RF, Wu GK. 1980. Effects of a single hit from the α hemolysin produced by Escherichia coli on the morphology of sheep erythrocytes. Infect. Immun. 27:988-994.
59. Collins BE, Blixt O, DeSieno AR, Bovin N, Marth JD, Paulson JC. 2004. Masking of CD22 by cis ligands does not prevent redistribution of CD22 to sites of cell contact. Proc. Natl. Acad. Sci. U. S. A. 101:6104-6109. http://dx.doi.org/10.1073/pnas.0400851101.
60. Brown AC, Balashova NV, Epand RM, Epand RF, Bragin A, Kachlany SC, Walters MJ, Du Y, Boesze-Battaglia K, Lally ET. 2013. Aggregatibacter actinomycetemcomitans leukotoxin utilizes a cholesterol recognition/amino acid consensus site for membrane association. J. Biol. Chem. 288:23607-23621. http://dx.doi.org/10.1074/jbc.M113.486654.
61. Ingraham LM, Burns CP, Boxer LA, Baehner RL, Haak RA. 1981. Fluidity properties and liquid composition of erythrocyte membranes in Chediak-Higashi syndrome. J. Cell Biol. 89:510-516. http://dx.doi.org/10.1083/jcb.89.3.510.
62. Bloom JA, Webb WW. 1983. Lipid diffusibility in the intact erythrocyte membrane. Biophys. J. 42:295-305. http://dx.doi.org/10.1016/S0006-3495(83)84397-5.
63. Stafford G, Roy S, Honma K, Sharma A. 2012. Sialic acid, periodontal pathogens and Tannerella forsythia: stick around and enjoy the feast! Mol. Oral Microbiol. 27:11-22. http://dx.doi.org/10.1111/j.2041-1014.2011.00630.x.
64. Hayashida H, Poulsen K, Kilian M. 2002. Differences in iron acquisition from human haemoglobin among strains of Actinobacillus actinomycetemcomitans. Microbiology 148:3993-4001.
65. Ratledge C, Dover LG. 2000. Iron metabolism in pathogenic bacteria. Annu. Rev. Microbiol. 54:881-941. http://dx.doi.org/10.1146/annurev.micro.54.1.881.
66. Beck JD, Eke P, Heiss G, Madianos P, Couper D, Lin D, Moss K, Elter J, Offenbacher S. 2005. Periodontal disease and coronary heart disease: a reappraisal of the exposure. Circulation 112:19-24. http://dx.doi.org/10.1161/CIRCULATIONAHA.104.511998.
67. Haraszthy VI, Zambon JJ, Trevisan M, Zeid M, Genco RJ. 2000. Identification of periodontal pathogens in atheromatous plaques. J. Periodontol. 71:1554-1560. http://dx.doi.org/10.1902/jop.2000.71.10.1554.
68. Kozarov EV, Dorn BR, Shelburne CE, Dunn WA, Jr, Progulske-Fox A. 2005. Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans and Porphyromonas gingivalis. Arterioscler. Thromb. Vasc. Biol. 25:e17-e18. http://dx.doi.org/10.1161/01.ATV.0000155018.67835.1a.
69. Pussinen PJ, Jousilahti P, Alfthan G, Palosuo T, Asikainen S, Salomaa V. 2003. Antibodies to periodontal pathogens are associated with coronary heart disease. Arterioscler. Thromb. Vasc. Biol. 23:1250-1254. http://dx.doi.org/10.1161/01.ATV.0000072969.71452.87.
70. Stenderup K, Rosada C, Dam TN, Salerno E, Belinka BA, Kachlany SC. 2011. Resolution of psoriasis by a leukocyte-targeting bacterial protein in a humanized mouse model. J. Invest. Dermatol. 131:2033-2039. http://dx.doi.org/10.1038/jid.2011.161.